![]() |
Volumn 189, Issue 6, 2001, Pages 377-383
|
The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia
a,b,c,d
d
NEPEC/182
*
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
ADULT;
ARTICLE;
BUDGET;
COST UTILITY ANALYSIS;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRESCRIPTION;
PUBLIC HOSPITAL;
SCHIZOPHRENIA;
STRESS;
ALZHEIMER DISEASE;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
BUDGETS;
CLOZAPINE;
COMORBIDITY;
DEPRESSIVE DISORDER;
DRUG COSTS;
FEMALE;
HEALTH CARE COSTS;
HEALTH FACILITIES;
HUMANS;
MALE;
MIDDLE AGED;
PHYSICIAN'S PRACTICE PATTERNS;
PIRENZEPINE;
REGRESSION ANALYSIS;
RISPERIDONE;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;
|
EID: 0034972851
PISSN: 00223018
EISSN: None
Source Type: Journal
DOI: 10.1097/00005053-200106000-00005 Document Type: Article |
Times cited : (30)
|
References (12)
|